Skip to content

NeuBase Therapeutics, Inc.: filings

Every NeuBase Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 51 filings, each linked to its SEC index.

Filing record ends 2023-11-09

The latest filing in this captured record is a 10-Q filed 2023-11-09. No later filing is in the SEC companyfacts record captured on 2026-09-22. NeuBase Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-09fiscal Q3 2023371110001558370-23-018577
10-Q2023-08-14fiscal Q2 2023371070001558370-23-014851
10-Q2023-05-11fiscal Q1 202337770001558370-23-009371
10-Q2023-02-14fiscal Q1 202337770001410578-23-000120
10-K2022-12-21fiscal FY 202242850001410578-22-003576
10-Q2022-08-11fiscal Q3 2022391140001410578-22-002236
10-Q2022-05-12fiscal Q2 2022381080001410578-22-001383
10-Q2022-02-11fiscal Q1 202240840001410578-22-000115
10-K2021-12-23fiscal FY 202140810001410578-21-000599
10-Q2021-08-13fiscal Q3 202135900001104659-21-105085
10-Q2021-05-14fiscal Q2 202130830001104659-21-066181
10-Q2021-02-11fiscal Q1 202130640001104659-21-020794
10-K2020-12-23fiscal FY 202034700001104659-20-139139
10-Q2020-08-13fiscal Q3 202034920001104659-20-094763
10-Q2020-05-14fiscal Q2 202035970001104659-20-061711
10-Q2020-03-26fiscal Q1 202034760001104659-20-038903
10-K2020-01-10fiscal FY 201934590001104659-20-003043
10-Q2019-08-14fiscal Q3 201925710001387131-19-006165
10-Q2019-05-15fiscal Q2 201925680001387131-19-003729
10-Q2019-02-14fiscal Q1 201923460001387131-19-001277
10-K2019-01-03fiscal FY 201829570001387131-19-000051
10-Q2018-08-14fiscal Q3 201826640001387131-18-004016
10-Q2018-05-15fiscal Q2 201827650001387131-18-002211
10-Q2018-02-14fiscal Q1 201827520001387131-18-000667
10-K2017-12-15fiscal FY 201729570001387131-17-005845
10-Q2017-08-08fiscal Q3 201722600001387131-17-003985
10-Q2017-05-11fiscal Q2 201722590001387131-17-002652
10-Q2017-02-14fiscal Q1 201722450001387131-17-000755
10-K2016-12-22fiscal FY 201624780001387131-16-008696
10-Q2016-08-09fiscal Q3 201621530001387131-16-006411
10-Q2016-05-10fiscal Q2 201621530001387131-16-005359
10-Q2016-02-09fiscal Q1 201620400001387131-16-004111
10-K2015-12-14fiscal FY 201525810001387131-15-003603
10-Q2015-08-06fiscal Q3 201522600001387131-15-002329
10-Q2015-05-11fiscal Q2 201525620001387131-15-001596
10-Q2015-02-10fiscal Q1 201524480001387131-15-000450
10-K2014-12-22fiscal FY 201428920001387131-14-004117
10-Q2014-08-18fiscal Q3 201428710001387131-14-003044
10-Q2014-05-13fiscal Q2 201425780001387131-14-001860
10-Q2014-02-14fiscal Q1 201425620001387131-14-000541
10-K2013-12-27fiscal FY 201325730001387131-13-004795
10-Q2013-08-13fiscal Q3 201325820001387131-13-002910
10-Q2013-05-14fiscal Q2 201325790001387131-13-001784
10-Q2013-02-19fiscal Q1 201327670001387131-13-000485
10-K2013-01-09fiscal FY 201224680001387131-13-000067
10-Q2012-08-07fiscal Q3 201223780001387131-12-002472
10-Q2012-05-11fiscal Q2 201225810001387131-12-001477
10-Q/A2012-02-14fiscal Q1 201229690001387131-12-000342
10-K/A2012-01-18fiscal FY 201125720001387131-12-000080
10-K2012-01-13fiscal FY 201125720001387131-12-000055
10-Q2011-08-15fiscal Q3 201127860001387131-11-001669

Inspect the source

Entity
NeuBase Therapeutics, Inc. / CIK 0001173281
Captured
SEC response SHA-256
0e0882fa147fcb0a3e5f3af54573abe947d9ade4d42095debd16c2d62da36e79

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001173281.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))